Showing results (181-190 of 969) with videos related to
Sort By:
Pageof 97
Current Opinion in Pharmacology|January 15, 2019
Clinical effectiveness of novel rosacea therapiesBrittany Feaster, Abigail Cline, Steven R Feldman, et al.The Journal of Dermatological Treatment|December 25, 2019
Secukinumab rapidly improves EQ-5D health status in patients with psoriasis: Pooled analysis from four phase 3 trialsSteven R Feldman, Braulio Gomez, Xiangyi Meng, et al.BMJ Case Reports|October 28, 2021
Tumid lupus erythematosus and systemic lupus erythematosus: a rare coexistenceAilia Ali, Alexander Woods, Caroline Porter, et al.Dermatology and Therapy|July 28, 2022
Reassurance Techniques Do Not Significantly Impact Confidence in Biosimilars for Psoriasis: A Survey of a Convenience Sample of Individuals with Self-Identified PsoriasisMatthew L Hrin, Jeremy K Bray, Steven R FeldmanJournal of Drugs in Dermatology : JDD|March 9, 2016
Costs of Common Psoriasis Medications, 2010-2014Sara M James, Dane E Hill, Steven R FeldmanDrugs|August 27, 2014
Rosacea: new and emerging treatmentsFarah A Moustafa, Laura F Sandoval, Steven R FeldmanJournal of Drugs in Dermatology : JDD|June 12, 2014
The duration of acne treatmentKaren E Huang, S Evan Carstensen, Steven R FeldmanThe Annals of Pharmacotherapy|March 28, 2023
Avacopan for the Treatment of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated VasculitisChristopher Alihosseini, Hannah Kopelman, Mallory Zaino, et al.The Journal of Dermatological Treatment|June 25, 2015
Biologics and biosimilarsPalak K Patel, Caleb R King, Steven R FeldmanCureus|February 27, 2023
Treatment Adherence in Dermatology During the COVID-19 Pandemic: A ReviewSarah G Bridgeman, Patrick O Perche, Steven R FeldmanPageof 97